Cargando…
Urinary 11‐Dehydro‐Thromboxane B(2) as a Predictor of Acute Myocardial Infarction Outcomes: Results of Leukotrienes and Thromboxane In Myocardial Infarction (LTIMI) Study
BACKGROUND: Urinary 11‐dehydro‐thromboxane (TX)B(2) has been described as a potential predictive biomarker of major adverse cardiovascular events (MACEs) in high cardiac risk patients. This part of LTIMI (Leukotrienes and Thromboxane In Myocardial Infarction) study aimed to evaluate the relationship...
Autores principales: | Szczeklik, Wojciech, Stodółkiewicz, Edyta, Rzeszutko, Marcin, Tomala, Marek, Chrustowicz, Anton, Żmudka, Krzysztof, Sanak, Marek |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5015290/ https://www.ncbi.nlm.nih.gov/pubmed/27481134 http://dx.doi.org/10.1161/JAHA.116.003702 |
Ejemplares similares
-
Influence of smoking and smoking cessation on levels of urinary 11-dehydro thromboxane B(2)
por: van der Plas, Angela, et al.
Publicado: (2018) -
Urine 11-Dehydro-Thromboxane B2 in Aspirin-Naive Males with Metabolic Syndrome
por: Piechota, Wiesław, et al.
Publicado: (2022) -
Left atrial contractile strain is the independent predictor of LV remodeling after ST-segment elevation myocardial infarction
por: Karwat, Krzysztof P, et al.
Publicado: (2015) -
Thromboxane Modulates Endothelial Permeability
por: Klausner, J. M., et al.
Publicado: (1994) -
Stability of thromboxane in blood samples
por: Helgadóttir, Helga, et al.
Publicado: (2019)